- Home
- ORKA vs RMR Comparison
ORKA vs RMR Comparison
Compare ORKA & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- RMR
- Stock Information
- Founded
- ORKA 2004
- RMR 1986
- Country
- ORKA United States
- RMR United States
- Employees
- ORKA N/A
- RMR N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RMR Professional Services
- Sector
- ORKA Health Care
- RMR Consumer Discretionary
- Exchange
- ORKA Nasdaq
- RMR Nasdaq
- Market Cap
- ORKA 354.2M
- RMR 290.8M
- IPO Year
- ORKA N/A
- RMR N/A
- Fundamental
- Price
- ORKA $14.21
- RMR $17.72
- Analyst Decision
- ORKA Strong Buy
- RMR
- Analyst Count
- ORKA 8
- RMR 0
- Target Price
- ORKA $39.71
- RMR N/A
- AVG Volume (30 Days)
- ORKA 360.1K
- RMR 119.6K
- Earning Date
- ORKA 08-15-2025
- RMR 08-05-2025
- Dividend Yield
- ORKA N/A
- RMR 10.17%
- EPS Growth
- ORKA N/A
- RMR N/A
- EPS
- ORKA N/A
- RMR 1.06
- Revenue
- ORKA N/A
- RMR $197,672,000.00
- Revenue This Year
- ORKA N/A
- RMR $323.25
- Revenue Next Year
- ORKA N/A
- RMR $1.07
- P/E Ratio
- ORKA N/A
- RMR $16.65
- Revenue Growth
- ORKA N/A
- RMR N/A
- 52 Week Low
- ORKA $5.49
- RMR $13.48
- 52 Week High
- ORKA $52.32
- RMR $26.43
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- RMR 68.35
- Support Level
- ORKA N/A
- RMR $16.94
- Resistance Level
- ORKA N/A
- RMR $17.80
- Average True Range (ATR)
- ORKA 0.00
- RMR 0.42
- MACD
- ORKA 0.00
- RMR 0.06
- Stochastic Oscillator
- ORKA 0.00
- RMR 94.90
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.